60
Views
9
CrossRef citations to date
0
Altmetric
Review

Profile of temsirolimus in the treatment of advanced renal cell carcinoma

, , &
Pages 191-196 | Published online: 15 Sep 2010

References

  • SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site [database on the Internet] 2008
  • EscudierBEisenTStadlerWMSzczylikCOudardSSiebelsMSorafenib in advanced clear-cell renal-cell carcinomaN Engl J Med2007356212513417215530
  • MotzerRJHutsonTETomczakPMichaelsonMDBukowskiRMRixeOSunitinib versus interferon alfa in metastatic renal-cell carcinomaN Engl J Med2007356211512417215529
  • HudesGCarducciMTomczakPDutcherJFiglinRKapoorATemsirolimus, interferon alfa, or both for advanced renal-cell carcinomaN Engl J Med2007356222271228117538086
  • EscudierBPluzanskaAKoralewskiPRavaudABracardaSSzczylikCBevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialLancet200737096052103211118156031
  • AtkinsMBHidalgoMStadlerWMLoganTFDutcherJPHudesGRRandomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinomaJ Clin Oncol200422590991814990647
  • MotzerRJBacikJMazumdarMPrognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experienceClin Cancer Res20041018 Pt 26302S6303S15448021
  • MotzerRJBacikJSchwartzLHReuterVRussoPMarionSPrognostic factors for survival in previously treated patients with metastatic renal cell carcinomaJ Clin Oncol200422345446314752067
  • LoganTMcDermottDFDutcherJPExploratory analysis of the influence of nephrectomy status on temsirolimus efficacy in patients with advanced renal cell carcinoma and poor-risk featuresJ Clin Oncol200826 (May 20 suppl):abstr 5050.
  • FlaniganRCMickischGSylvesterRTangenCVan PoppelHCrawfordEDCytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysisJ Urol200417131071107614767273
  • MickischGHGarinAvan PoppelHde PrijckLSylvesterRRadical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialLancet2001358928696696011583750
  • MotzerRJMazumdarMBacikJBergWAmsterdamAFerraraJSurvival and prognostic stratification of 670 patients with advanced renal cell carcinomaJ Clin Oncol19991782530254010561319
  • DutcherJPde SouzaPMcDermottDFiglinRABerkenblitAThieleAEffect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologiesMed Oncol200926220220919229667
  • DutcherJPde SouzaPFiglinREffect of temsirolimus versus interferon-α on survival of patients with advanced renal cell carcinoma of different tumor histologiesClin Oncol200826 (May 20 suppl):abstr 384
  • FiglinRAde SouzaPMcDermottDDutcherJPBerkenblitAThieleAAnalysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alphaCancer2009163651366019526589
  • EscudierBGoupilMGMassardCFizaziKSequential therapy in renal cell carcinomaCancer200911510 Suppl2321232619402067